Matrix Medical
Incorporating Prognostic Gene Expression Profiling in the Management of Skin Cancer

Shannon Trotter, DO, FAOCD, FAAD
Clinical Assistant Professor
Ohio University
Columbus, Ohio

James E. Sligh, MD, PhD, FAAD
Dermatologist
Bay Pines VA Medical Center
Bay Pines, Florida

Video On Demand

This activity is approved for AMA PRA Category 1 Credit(s)™.

Drs. Trotter and Sligh hosted a live Q&A session on the content discussed in this webinar. Register for free to be part of the webinar.

This activity has been developed to meet the educational needs of dermatologists, nurse practitioners, physician assistants, and staff who are dedicated to the management of patients with cutaneous melanoma and cutaneous squamous cell carcinoma.

 

Learning Objectives

  • Review the incidence and prevalence of melanoma in the United States
  • Discuss NCCN's guidelines regarding a patient's individual risk of recurrence
  • Identify the value of the 31-gene expression profile for cutaneous melanoma to assess individual risk of sentinel lymph node positivity to improve patient selection for the surgical procedure
  • Discuss the value of the 31-gene expression profile for cutaneous melanoma to accurately predict individual risk of recurrence or metastasis to inform decisions on intensity of follow-up, surveillance imaging, patient referrals, and consideration of adjuvant therapy/clinical trial participation
  • Describe the value of the 40-gene expression profile for cutaneous squamous cell carcinoma to predict individual metastatic risk to inform risk-appropriate management decisions

     

 

Commercial Support
This activity is supported by educational grant from Castle BioSciences

Joint Providership
Matrix Medical Communications, LLC and Cinè-Med

Accreditation
In support of improving patient care, this activity has been planned and implemented by Cinè-Med and Matrix Medical Communications. Cinè-Med is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Cinè-Med designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.